United States

Zhejiang Huahai Pharmaceutical Co Ltd (600521.SS)

600521.SS on Shanghai Stock Exchange

16 Mar 2018
Change (% chg)

¥-0.64 (-2.19%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Wed, Feb 7 2018

BRIEF-Zhejiang Huahai Pharmaceutical's Preliminary 2017 Net Profit Up 26.45 Pct Y/Y

* SAYS PRELIM 2017 NET PROFIT UP 26.45 PERCENT Y/Y AT 633.29 MILLION YUAN ($101.16 million) Source text in Chinese: http://bit.ly/2Bf04WM Further company coverage: ($1 = 6.2600 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Zhejiang Huahai Pharmaceutical says fire accident in unit's warehouse

* Says fire accident has occurred at a warehouse of co's Zhejiang-based wholly owned pharmaceutical unit, on Jan. 18

BRIEF-Zhejiang Huahai Pharmaceutical to invest in pharma industry park project

* Says it plans to invest in pharma industry park project with total investment at about 10 billion yuan ($1.50 billion)

BRIEF-Zhejiang Huahai Pharmaceutical passes U.S. FDA approval

* Says it received approval for a kind of tablet, which is used for treatment of chronic hepatitis B, from U.S. Food and Drug Administration

BRIEF-Zhejiang Huahai Pharmaceutical passes FDA approval

* Says it received approval for its production base of API from U.S Food and Drug Administration

Select another date: